Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness.

Kashuba, Angela D. M.Gengiah, Tanuja Narayansamy.Werner, Lise.Yang, Kuo-Hsiung.White, Nicole R.Abdool Karim, Quarraisha.Abdool Karim, Salim Safurdeen.2016-11-162016-11-1620152015Kashuba, A.D., Gengiah, T.N., Werner, L., Yang, K.H., White, N.R., Abdool Karim, Q. and Abdool Karim, S.S. 2015. Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness. Journal of Acquired Immune Deficiency Syndromes 69(3), 264-269.http://dx.doi.org/10.1097/QAI.0000000000000607http://hdl.handle.net/10413/13716CAPRISA, 2015.Abstract available in pdf.enTenofovir.Genital tract.HIV.Protection.Adherence.Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness.Peer reviewed journal article